Atrial Fibrillation TRIal of Left Atrial Appendage Closure Using Seralene Hemostatic Suture

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 200 participants.

Also called NCT07360899

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07360899
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Serbia (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07360899. Allocation not applicable; no masking; primary purpose treatment. Start 2025-12-01 (actual); primary completion 2026-04-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Atrial Fibrillation TRIal of Left Atrial Appendage Closure Using Seralene Hemostatic Suture
Acronym
ATRI-LASH
Condition
ATRIAL APPENDAGE CLOSURE for ATRIAL FIBRILLATION
Condition
Atrial Fibrillation (AF)
Condition
Mitral Valve Surgery
Condition
Stroke (in Patients With Atrial Fibrillation)
Condition
Anticoagulant Therapy
Intervention (Device)
LAA closure using the AtriLASH
Lead sponsor
Institute of Cardiovascular Diseases, Vojvodina (class: other)
Collaborator
Institute for Cardiovascular Diseases Dedinje (class: other)
Collaborator
KBC Rebro Zagreb (class: not stated)
Collaborator
Clinical Centre of Serbia (class: other)

Record details

Record id
cardio:ct-nct07360899
Content hash
92020dc7456edc5d9a94d9380eafe4a011191f892d6646f7524b27b56931eeba